Skip to content

Anxiety: all studies

Page 36 of 770: studies 351 to 360 of 7,695, newest first. Back to the anxiety overview

Research

Preprocessing-Oriented EEG Analysis for Measuring Stress and Anxiety Alleviation curtailment by Mantra Meditation

2025 IEEE 1st International Conference on Recent Trends in Computing and Smart Mobility December 5, 2025 Vandana Roy, P. Shukla

Electroencephalography (EEG) is becoming the key technique of researching mental states, particularly when studies focus on stress and anxiety. Regrettably, EEG recordings are routinely contaminated by numerous sources of noise, including power line noise, motion artifacts, burst noise, Electrooculography (EOG), Electromyography (EMG), and Electrocardiography (ECG), which severely affect the...

Spiritual Mindfullness Combination Breathing Exercise Toward Anxiety, Depression and Blood Pressure in Ischemic Stroke Survivors

Journal of Cultural Analysis and Social Change December 4, 2025 Eppy Setiyowati, Nur Hidaayah, Mulyadi Mulyadi et al.

In general, ischemic stroke patients experience psychological problems anxiety, depression and increased blood pressure to be above normal. The purpose of the study was to analyze anxiety, depression and blood pressure post mindfulness spiritual intervention combination breathing exercise. Quasy experiment research design with a large sample of 25 respondents through purposive sampling...

Rewiring the Aging Mind: A Randomized Controlled Trial on the Transformative Impact of Mindfulness-based Cognitive Behavioural Therapy on Depression and Anxiety

Journal of Ecophysiology and Occupational Health December 2, 2025 Rachna Garg, Shubhagata Awasthi, Naveen Gupta

The rising incidence of depression and anxiety among the elderly is a growing public health concern. While pharmacological treatments are widely used, they often present challenges such as side effects and dependency, highlighting the need for evidence-based psychotherapeutic alternatives. Mindfulness-Based Cognitive Behavioral Therapy (MBCBT) integrates mindfulness techniques with cognitive...

Efficacy of psilocybin on death anxiety in terminal patients: a narrative review

Progress in Palliative Care December 1, 2025 M. Barimbing, D. Jeger, Made Edwin Sridana

ABSTRACT This narrative review synthesized the use of psilocybin-assisted therapy as a promising treatment for alleviating death anxiety in terminally ill patients. The insights presented are derived from findings reported in previous studies. Therefore, this review aimed to assess the efficacy, pharmacology, and mechanisms by which psilocybin alters brain function by affecting 5-HT2A receptors...

Cannabis Use is Related to Anhedonia in Adolescents With Diverse Mood and Anxiety Symptoms.

JAACAP open December 1, 2025 Tram N B Nguyen, Benjamin A Ely, Aria Vitale et al.

Youth with depression use cannabis at high rates, and exposure to cannabinoids in adolescence has been shown to deleteriously alter the reward system. However, there has been sparse research on the link between adolescent cannabis use and anhedonia, a core symptom of depression and clinical manifestation of reward dysfunction. Here, in a sample of adolescents presenting predominantly with mood...

The relationship between 3,4-methylenedioxymethamphetamine (MDMA) use in young adulthood and anxiety or depressive disorders in the mid-30s: Findings from the Victorian Adolescent Health Cohort Study.

Addiction December 1, 2025 Zachary Bryant, Kirsten Morley, Jessica A Kerr et al.

MDMA (3,4-methylenedioxymethamphetamine or "Ecstasy") is the fourth-most used illicit substance globally. While previous research found links between MDMA use and mental health outcomes, the direction and nature of this relationship remain unclear. This study assessed whether MDMA use in early adulthood increases the risk of anxiety or depression in mid-30s. A longitudinal, population-based...

Therapeutic potential of slow pranayama in anxiety.

Journal of Family Medicine and Primary Care December 1, 2025 Neena Sharma, Kamlesh Jha, Chandrakanta Munni

Pranayama, yogic breathing techniques, are considered a form of meditation. In classical yoga, the breath is associated with prana; thus, pranayama is a means to control the inner force, the prana shakti or life energy. Pranayama is more than regular breathing and if practiced in structured and methodical manner can reduce the body's physical symptoms of stress and anxiety. It has more recently...

The effect of mindfulness meditation on anxiety among justice-involved adolescents

Nurse Professional Education Journal November 30, 2025 Nopiandi Wardani, I Made Eka Santosa, Ni Made Sumartyawati

Anxiety can harm behavior, social functioning, and the rehabilitation process, especially in adolescents in conflict with the law. This study aims to analyze the effect of mindfulness meditation therapy on anxiety levels in adolescents in conflict with the law at the Paramita Mataram Center. The study used a quantitative approach with a one-group pre-test post-test pre-experimental design. All...

Ketamine attenuates anxiety-like behavior and oxidative imbalance in the maternal immune activation model: emphasis on the cerebellum.

Psychopharmacology November 28, 2025 Elifrances Galdino de Oliveira, Mayara Victória De Souza Barbosa, Diógenes Afonso De Lima et al.

Relevant to the study of neurodevelopmental disorders, maternal immune activation (MIA) models reproduce the high incidence of anxiety disorders and molecular alterations in the cerebellum reported in patients with schizophrenia and autism. In parallel, ketamine, a fast-acting antidepressant, has shown beneficial effects in psychiatric disorders with immune-related components. To investigate...

Single dose of LSD formulation improves anxiety in Phase 2b trial

The Brown University Psychopharmacology Update November 28, 2025

Treatment with a single dose of a pharmaceutical formulation of lysergic acid diethylamide (LSD) resulted in a dose‐dependent reduction in anxiety in individuals with generalized anxiety disorder (GAD), a Phase 2b study has found. The two highest of four tested dose strengths of the MM120 formulation demonstrated significant improvement relative to placebo.